• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® HYBRID VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number 0650HYB0605
Device Problem Malposition of Device (2616)
Patient Problems Occlusion (1984); Renal Failure (2041)
Event Date 04/17/2015
Event Type  Injury  
Event Description
During an article review, with the title ¿results of the gore® hybrid vascular graft in challenging aortic branch revascularization during complex aneurysm repair¿, published in the journal annals of vascular surgery in 2015 from nikolaos tsilimparis, md et all, following was noted: a retrospective analysis of 12 patients treated with the gore® hybrid vascular graft was performed.Indication for gore® hybrid vascular graft implantation included difficult access to target vessel and surgeon¿s decision to reduce organ ischemia time during revascularization.The procedures in which the gore® hybrid vascular graft was considered were visceral debranching procedures prior to thoracoabdominal stent-grafting, as well as challenging revascularization of renal and hypogastric arteries.Within a 26-month period 25 gore® hybrid grafts were implanted in 12 patients.Technical success was achieved in all cases.Beside this information, following was reported: in one case, a side branch of the renal artery perfusing a third of the ipsilateral kidney was covered with the stent graft of the gore® hybrid vascular graft, thus resulting in partial infarction of the respective kidney segment without relevant worsening of renal function.
 
Manufacturer Narrative
Further investigation is being conducted and the information will be included in the final report.
 
Manufacturer Narrative
Date when partial infarction of the respective kidney segment was observed remains unknown.Therefore date when literature article was accepted will be taken as event date.The review of the manufacturing records verified that this lot met all pre-release specifications.Udi # for lot 10109675: (b)(4).Added literature to report source: w.L.Gore & associates received two lot numbers which were implanted during the procedure (lot # 10109675 and lot # 10120460).According to the physician it is unclear which lot covered a side branch of the renal artery.Therefore gore is submitting a report for each lot reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® HYBRID VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
barbara ulrich
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key4951932
MDR Text Key6254353
Report Number2017233-2015-00474
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K093934
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative,lit
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/02/2014
Device Catalogue Number0650HYB0605
Device Lot Number10109675
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/29/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age33 YR
-
-